14-day Premium Trial Subscription Sign Up For FreeGet Free

Celldex Therapeutics Stock Forecast NASDAQ:CLDX

Price Target and Analyst Ratings

Most Recent Rating

On September 17, 2021 "Jefferies Financial Group" gave "" rating for CLDX. The price target was set to $53.28+0.1%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-17 Initiated by Jefferies Financial Group $54.39 $53.28+0.1%
2021-09-13 $54.00 - $60.00 Target Raised by HC Wainwright $54.06 $54.75+0.4%
2021-09-10 $68.00 Initiated by SVB Leerink $54.52 $53.76→2.6%
2021-08-06 $50.00 - $54.00 Target Raised by HC Wainwright $47.60 $47.70+6.4%
2021-07-22 $66.00 Initiated by Guggenheim $44.33 $43.30→0.3%
2021-07-12 $36.00 - $50.00 Target Raised by HC Wainwright $40.67 $32.41+4.2%
2021-03-01 Buy Target Raised by HC Wainwright $28.19 $25.00 → $36.00
2021-02-23 Buy Target Raised by HC Wainwright $27.71 $25.00 → $36.00
2021-02-23 Overweight Target Raised by Cantor Fitzgerald $27.71 $22.00 → $35.00
2020-11-17 Outperform Reiterated by Lifesci Capital $19.02
2020-10-19 Buy Target Raised by HC Wainwright $16.20 $16.00 → $25.00
2020-07-01 Overweight Target Raised by Cantor Fitzgerald $13.38 $12.00 → $18.00
2020-06-12 Overweight Target Raised by Cantor Fitzgerald $7.80 $8.00 → $12.00

CLDX Stock Trend

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 60.76% during the next 3 months and, with a 90% probability hold a price between $78.61 and $92.17 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-30 $49.24 $53.46 $57.68
2021-10-01 $49.59 $53.81 $58.02
2021-10-04 $49.93 $54.15 $58.37
2021-10-05 $50.28 $54.49 $58.71
2021-10-06 $50.62 $54.84 $59.06
2021-10-07 $50.96 $55.18 $59.40
2021-10-08 $51.31 $55.53 $59.74
2021-10-11 $51.65 $55.87 $60.09
2021-10-12 $52.00 $56.21 $60.43
2021-10-13 $52.34 $56.56 $60.78
2021-10-14 $52.68 $56.90 $61.12
2021-10-15 $53.03 $57.25 $61.46
2021-10-18 $53.37 $57.59 $61.81
2021-10-19 $53.72 $57.93 $62.15
2021-10-20 $54.06 $58.28 $62.50
2021-10-21 $54.40 $58.62 $62.84
2021-10-22 $54.75 $58.97 $63.18
2021-10-25 $55.09 $59.31 $63.53
2021-10-26 $55.43 $59.65 $63.87
2021-10-27 $55.78 $60.00 $64.22
2021-10-28 $56.12 $60.34 $64.56
2021-10-29 $56.47 $60.69 $64.90
2021-11-01 $56.81 $61.03 $65.25
2021-11-02 $57.15 $61.37 $65.59
2021-11-03 $57.50 $61.72 $65.94
2021-11-04 $57.84 $62.06 $66.28
2021-11-05 $58.19 $62.40 $66.62
2021-11-08 $58.53 $62.75 $66.97
2021-11-09 $58.87 $63.09 $67.31
2021-11-10 $59.22 $63.44 $67.66

About Celldex Therapeutics

Celldex Therapeutics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care in the United States. The company’s lead drug candidates comprise Rintega (CDX-110), a therapeutic vaccine in Phase III clinical studies for the treatment of glioblastoma patients that express an epidermal growth factor receptor variant III, as well as in Phase II study for the treatment of recurrent gliobl... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT